Heart Failure Pharmacology
Sort by:
ACC 2024 Insights
ACC 2024 Insights: What Should the Cardiologist Know About AL Amyloidosis?
FEATURING
Renee Bullock-Palmer
- 2 views
- May 3, 2024
ACC 2024 Insights
ACC 2024 Insights: Pearls of HFpEF Management - Lessons Learned from Running a Dedicated HFpEF Clinic
FEATURING
Sheldon Litwin
- 11 views
- April 30, 2024
ACC 2024 Insights
ACC 2024 Insights: Stop the Meds! Treat the Comorbidities for Optimal Outcomes
FEATURING
Kim Williams
- 22 views
- April 26, 2024
Scripps Health
What's New in Outpatient HF Management
FEATURING
Rajeev Mohan
- 377 views
- April 26, 2024
- 5
CVRx | Barostim
Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)
FEATURING
J. Thomas Heywood
- 47 views
- April 24, 2024
Houston Methodist Hospital
Treatment Options for TTR Amyloid: Current and Future
FEATURING
Ronald Witteles
- 47 views
- April 19, 2024
Houston Methodist Hospital
Treatment Options for AL Amyloidosis
FEATURING
Angela Dispenzieri
- 4 views
- April 19, 2024
Houston Methodist Hospital
Amyloidosis Types and Pathophysiology
FEATURING
Barry Trachtenberg
- 83 views
- April 19, 2024
- 3
ACC 2024 Insights
ACC 2024 Insights: Evolving Pharmacology for HFrEF vs. HFpFF - With or Without Chronic Kidney Disease and/or Diabetes
FEATURING
Maria Costanzo
- 1,153 views
- April 16, 2024
- 17
ACC 2024 Insights
ACC 2024 Insights: Plozasiran (ARO-APOC3), An Investigational RNAi Therapeutic, Demonstrates Profound and Durable Reductions In APOC-3 and Triglycerides (TG) in Patients With Severe Hypertriglyceridemia (SHTG), SHASTA-2 Final Results
FEATURING
Daniel Gaudet
- 59 views
- April 16, 2024
- 1
University of Louisville
Implementation of Evidence Based Medicine
FEATURING
Javed Butler
- 18 views
- March 21, 2024
The Texas Heart Institute
Percutaneous Device Options for the Management of Heart Failure – Present and Future Perspectives
FEATURING
Nikolaos Diakos
- 67 views
- March 14, 2024
- 1
The Texas Heart Institute
Current Guidelines and Management Strategies in Heart Failure
FEATURING
Biykem Bozkurt
- 1,000 views
- March 14, 2024
- 6
ARCH Advanced Revascularization Symposium
Ischemic Cardiomyopathy and Revascularization – Is My Approach Different Now?
FEATURING
Scott Harding
- 40 views
- March 12, 2024
UChicago Medicine
Peripartum Cardiomyopathy: Diagnosis and Management of Pregnancy Related Heart Failure
FEATURING
Hena Patel
- 39 views
- March 12, 2024
UChicago Medicine
S-QUAD Therapy and Beyond: HFpEF in 2024
FEATURING
Mark Belkin
- 122 views
- March 12, 2024
- 3
UChicago Medicine
Amyloidosis: The Forgotten Protein
FEATURING
Nitasha Sarswat
- 56 views
- March 12, 2024
- 1
UChicago Medicine
Not so Strong with the Force: Cardiac Myosin Inhibitor Therapy in Hypertrophic Cardiomyopathy
FEATURING
Gene Kim
- 359 views
- March 12, 2024
- 1
UChicago Medicine
Graduation, Now What?: Heart Failure Management After Medication Titration Program Completion
FEATURING
Rachel Lavelle, Pharmd
- 9 views
- March 8, 2024